| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | mitotic cell cycle | MIIP ROCK2 USP26 KNTC1 SETD2 PPP2R5C GBF1 CLTCL1 CENPF ANP32B BAZ1B BCCIP MCM6 DAXX KIF11 CCND2 | 6.20e-06 | 1014 | 89 | 16 | GO:0000278 |
| GeneOntologyBiologicalProcess | cell cycle process | MIIP ROCK2 USP26 KNTC1 SETD2 PPP2R5C CENPF ANP32B SHOC1 BAZ1B BCCIP MCM6 DAXX CEP152 EIF2AK4 RAB11FIP4 KIF11 CCND2 NIN | 9.94e-06 | 1441 | 89 | 19 | GO:0022402 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | MIIP ROCK2 USP26 KNTC1 SETD2 PPP2R5C CENPF ANP32B BAZ1B BCCIP MCM6 DAXX KIF11 CCND2 | 1.66e-05 | 854 | 89 | 14 | GO:1903047 |
| GeneOntologyBiologicalProcess | ventricular system development | 2.14e-05 | 38 | 89 | 4 | GO:0021591 | |
| GeneOntologyBiologicalProcess | cell division | ROCK2 KNTC1 SETD2 CENPF SSNA1 NAP1L2 LRP6 FGF7 DAXX RAB11FIP4 KIF11 CCND2 | 4.43e-05 | 697 | 89 | 12 | GO:0051301 |
| GeneOntologyCellularComponent | microtubule organizing center | ROCK2 DLG5 ODF2L TRAF5 CENPF UBR4 SSNA1 TSGA10 TSSK2 BCCIP CEP152 IRS1 RAB11FIP4 TEX9 CCND2 NIN | 7.78e-07 | 919 | 85 | 16 | GO:0005815 |
| GeneOntologyCellularComponent | centriole | 6.50e-06 | 172 | 85 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | centrosome | ROCK2 ODF2L TRAF5 CENPF UBR4 SSNA1 BCCIP CEP152 RAB11FIP4 TEX9 CCND2 NIN | 6.39e-05 | 770 | 85 | 12 | GO:0005813 |
| GeneOntologyCellularComponent | spindle pole | 1.90e-04 | 205 | 85 | 6 | GO:0000922 | |
| GeneOntologyCellularComponent | spindle | 6.61e-04 | 471 | 85 | 8 | GO:0005819 | |
| GeneOntologyCellularComponent | ciliary transition fiber | 7.20e-04 | 10 | 85 | 2 | GO:0097539 | |
| GeneOntologyCellularComponent | cilium | USP26 DLG5 ODF2L KIF27 CENPF SSNA1 TSGA10 IRS1 TSSK1B DNAH5 NIN | 1.01e-03 | 898 | 85 | 11 | GO:0005929 |
| GeneOntologyCellularComponent | ciliary basal body | 1.20e-03 | 195 | 85 | 5 | GO:0036064 | |
| MousePheno | enlarged stomach | 2.50e-05 | 33 | 73 | 4 | MP:0003883 | |
| Domain | AWS | 2.17e-04 | 5 | 88 | 2 | SM00570 | |
| Domain | WHIM1 | 2.17e-04 | 5 | 88 | 2 | PF15612 | |
| Domain | PKNOX/Meis_N | 2.17e-04 | 5 | 88 | 2 | IPR032453 | |
| Domain | AWS | 2.17e-04 | 5 | 88 | 2 | PS51215 | |
| Domain | AWS_dom | 2.17e-04 | 5 | 88 | 2 | IPR006560 | |
| Domain | Meis_PKNOX_N | 2.17e-04 | 5 | 88 | 2 | PF16493 | |
| Domain | WHIM1_dom | 2.17e-04 | 5 | 88 | 2 | IPR028942 | |
| Domain | DDT | 3.25e-04 | 6 | 88 | 2 | PS50827 | |
| Domain | PLipase_A2_Asp_AS | 3.25e-04 | 6 | 88 | 2 | IPR033112 | |
| Domain | Phospholip_A2_1 | 6.03e-04 | 8 | 88 | 2 | PF00068 | |
| Domain | PA2c | 7.73e-04 | 9 | 88 | 2 | SM00085 | |
| Domain | PLipase_A2 | 9.64e-04 | 10 | 88 | 2 | IPR001211 | |
| Domain | PLipase_A2_His_AS | 9.64e-04 | 10 | 88 | 2 | IPR033113 | |
| Domain | PA2_HIS | 1.17e-03 | 11 | 88 | 2 | PS00118 | |
| Domain | PA2_ASP | 1.17e-03 | 11 | 88 | 2 | PS00119 | |
| Domain | SET | 1.33e-03 | 46 | 88 | 3 | SM00317 | |
| Domain | PLipase_A2_dom | 1.40e-03 | 12 | 88 | 2 | IPR016090 | |
| Domain | - | 1.40e-03 | 12 | 88 | 2 | 1.20.90.10 | |
| Domain | ZF_TRAF | 1.66e-03 | 13 | 88 | 2 | PS50145 | |
| Domain | SET_dom | 1.69e-03 | 50 | 88 | 3 | IPR001214 | |
| Domain | SET | 1.69e-03 | 50 | 88 | 3 | PS50280 | |
| Domain | SIAH-type | 2.52e-03 | 16 | 88 | 2 | IPR013323 | |
| Domain | Post-SET_dom | 2.52e-03 | 16 | 88 | 2 | IPR003616 | |
| Domain | PostSET | 2.52e-03 | 16 | 88 | 2 | SM00508 | |
| Domain | POST_SET | 2.52e-03 | 16 | 88 | 2 | PS50868 | |
| Domain | Homeobox_KN | 2.85e-03 | 17 | 88 | 2 | PF05920 | |
| Domain | Homeobox_KN_domain | 2.85e-03 | 17 | 88 | 2 | IPR008422 | |
| Domain | RING | 3.19e-03 | 305 | 88 | 6 | SM00184 | |
| Domain | Zinc_finger_PHD-type_CS | 3.58e-03 | 65 | 88 | 3 | IPR019786 | |
| Domain | LRR_1 | 3.77e-03 | 219 | 88 | 5 | PF00560 | |
| Domain | Znf_RING | 4.41e-03 | 326 | 88 | 6 | IPR001841 | |
| Domain | - | 5.28e-03 | 449 | 88 | 7 | 3.30.40.10 | |
| Domain | ARM-type_fold | 5.33e-03 | 339 | 88 | 6 | IPR016024 | |
| Domain | PHD | 5.34e-03 | 75 | 88 | 3 | PF00628 | |
| Domain | TRAF-like | 5.66e-03 | 24 | 88 | 2 | IPR008974 | |
| Domain | Znf_RING/FYVE/PHD | 5.94e-03 | 459 | 88 | 7 | IPR013083 | |
| Domain | Znf_PHD-finger | 6.18e-03 | 79 | 88 | 3 | IPR019787 | |
| Domain | P-loop_NTPase | 6.49e-03 | 848 | 88 | 10 | IPR027417 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | 3.04e-09 | 8 | 91 | 4 | 12634303 | |
| Pubmed | ROCK2 KNTC1 SH3TC2 SETD2 GBF1 TLR1 POP1 LTN1 CEP152 PPP6R2 PRDM16 | 7.09e-08 | 493 | 91 | 11 | 15368895 | |
| Pubmed | 2.71e-06 | 332 | 91 | 8 | 37433992 | ||
| Pubmed | 2.86e-06 | 234 | 91 | 7 | 36243803 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | 3.33e-06 | 588 | 91 | 10 | 38580884 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 28754676 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 31060750 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19475691 | ||
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 19546233 | ||
| Pubmed | Dynamic histone H3 methylation during gene induction: HYPB/Setd2 mediates all H3K36 trimethylation. | 6.77e-06 | 2 | 91 | 2 | 18157086 | |
| Pubmed | 6.77e-06 | 2 | 91 | 2 | 16734387 | ||
| Pubmed | 8.34e-06 | 653 | 91 | 10 | 22586326 | ||
| Pubmed | 1.02e-05 | 187 | 91 | 6 | 26460568 | ||
| Pubmed | 1.04e-05 | 399 | 91 | 8 | 35987950 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DST MARS1 UBR4 POP1 RSF1 LTN1 BAZ1B MCM6 PRR14L DDX60L LARP4 IFI16 GOLGA4 KIF11 | 1.11e-05 | 1353 | 91 | 14 | 29467282 |
| Pubmed | 1.96e-05 | 210 | 91 | 6 | 16565220 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 GBF1 KIF27 CENPF MARS1 ANP32B UBR4 BAZ1B BCCIP MCM6 STIP1 DNAH5 GOLGA4 KIF11 | 1.97e-05 | 1425 | 91 | 14 | 30948266 |
| Pubmed | Evolution of testis-specific kinases TSSK1B and TSSK2 in primates. | 2.03e-05 | 3 | 91 | 2 | 23258646 | |
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 25738424 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 22855445 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 26468536 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 9651519 | ||
| Pubmed | 2.03e-05 | 3 | 91 | 2 | 12412021 | ||
| Pubmed | KNTC1 CLTCL1 TRAFD1 MTX2 DST MARS1 ANP32B UBR4 POP1 LTN1 STIP1 DDX60L FHIP2A IFI16 | 2.21e-05 | 1440 | 91 | 14 | 30833792 | |
| Pubmed | PPP2R5C MARS1 KRT84 POP1 LTN1 NSD1 PEX1 BAZ1B HINT3 EIF2AK4 KIF11 CCND2 | 2.59e-05 | 1084 | 91 | 12 | 11544199 | |
| Pubmed | Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism. | MIIP ROCK2 SLIT2 KLHL2 ODF2L CLTCL1 RSF1 DAXX LARP4 KIF11 FILIP1L | 3.03e-05 | 925 | 91 | 11 | 28986522 |
| Pubmed | 3.11e-05 | 228 | 91 | 6 | 30471916 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 3.79e-05 | 349 | 91 | 7 | 25665578 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 10781952 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 32929285 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 23818951 | ||
| Pubmed | TSKS concentrates in spermatid centrioles during flagellogenesis. | 4.05e-05 | 4 | 91 | 2 | 18495105 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 29729186 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 24790153 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 20103709 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 22348058 | ||
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 19828695 | ||
| Pubmed | The kinetochore protein, CENPF, is mutated in human ciliopathy and microcephaly phenotypes. | 4.05e-05 | 4 | 91 | 2 | 25564561 | |
| Pubmed | A novel family of serine/threonine kinases participating in spermiogenesis. | 4.05e-05 | 4 | 91 | 2 | 9412477 | |
| Pubmed | Targeted deletion of Tssk1 and 2 causes male infertility due to haploinsufficiency. | 4.05e-05 | 4 | 91 | 2 | 18533145 | |
| Pubmed | 4.05e-05 | 4 | 91 | 2 | 20053632 | ||
| Pubmed | 4.23e-05 | 146 | 91 | 5 | 21399614 | ||
| Pubmed | ATRX promotes heterochromatin formation to protect cells from G-quadruplex DNA-mediated stress. | 4.31e-05 | 26 | 91 | 3 | 34162889 | |
| Pubmed | Transcriptional profiling of sequentially generated septal neuron fates. | 4.31e-05 | 26 | 91 | 3 | 34851821 | |
| Pubmed | ROCK2 PDE2A DST CENPF ARHGAP44 UBR4 NSD1 STIP1 PPP6R2 GOLGA4 KIF11 | 4.36e-05 | 963 | 91 | 11 | 28671696 | |
| Pubmed | 5.47e-05 | 653 | 91 | 9 | 33742100 | ||
| Pubmed | DDX31 ANKRD20A4P ANP32B SHOC1 ANKRD20A2P ANKRD20A3P ANKRD20A1 | 5.48e-05 | 370 | 91 | 7 | 15164053 | |
| Pubmed | Dual Roles of Group IID Phospholipase A2 in Inflammation and Cancer. | 6.74e-05 | 5 | 91 | 2 | 27226632 | |
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 39390582 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 33135541 | ||
| Pubmed | 6.74e-05 | 5 | 91 | 2 | 15044604 | ||
| Pubmed | 8.27e-05 | 87 | 91 | 4 | 37495603 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 8.65e-05 | 861 | 91 | 10 | 36931259 | |
| Pubmed | 8.78e-05 | 399 | 91 | 7 | 37536630 | ||
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 23599433 | ||
| Pubmed | Histone H2A ubiquitination inhibits the enzymatic activity of H3 lysine 36 methyltransferases. | 1.01e-04 | 6 | 91 | 2 | 24019522 | |
| Pubmed | 1.01e-04 | 6 | 91 | 2 | 20729278 | ||
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | 1.11e-04 | 179 | 91 | 5 | 36261009 | |
| Pubmed | 1.26e-04 | 97 | 91 | 4 | 22360420 | ||
| Pubmed | DLG5 SETD2 PPP2R5C DDX31 DST MARS1 POP1 LTN1 NSD1 BAZ1B DAXX STIP1 NDUFA8 | 1.39e-04 | 1497 | 91 | 13 | 31527615 | |
| Pubmed | Deletion of 150 kb in the minimal DiGeorge/velocardiofacial syndrome critical region in mouse. | 1.41e-04 | 7 | 91 | 2 | 10545603 | |
| Pubmed | 1.52e-04 | 304 | 91 | 6 | 32235678 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.80e-04 | 942 | 91 | 10 | 31073040 | |
| Pubmed | 1.85e-04 | 42 | 91 | 3 | 18985028 | ||
| Pubmed | 1.88e-04 | 8 | 91 | 2 | 10531313 | ||
| Pubmed | 1.88e-04 | 8 | 91 | 2 | 8776594 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.97e-04 | 774 | 91 | 9 | 15302935 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PHKA2 GBF1 DST LRRIQ1 MARS1 ANP32B UBR4 MCM6 STIP1 ENO2 KIF11 | 2.06e-04 | 1149 | 91 | 11 | 35446349 |
| Pubmed | 2.07e-04 | 322 | 91 | 6 | 26514267 | ||
| Pubmed | 2.12e-04 | 44 | 91 | 3 | 30146317 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.23e-04 | 208 | 91 | 5 | 33230847 | |
| Pubmed | Substrate specificity analysis and novel substrates of the protein lysine methyltransferase NSD1. | 2.41e-04 | 9 | 91 | 2 | 24412544 | |
| Pubmed | 2.41e-04 | 9 | 91 | 2 | 11092979 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 2.77e-04 | 639 | 91 | 8 | 23443559 | |
| Pubmed | 2.95e-04 | 645 | 91 | 8 | 25281560 | ||
| Pubmed | 3.01e-04 | 10 | 91 | 2 | 16081822 | ||
| Pubmed | 3.01e-04 | 10 | 91 | 2 | 26828067 | ||
| Pubmed | 3.01e-04 | 10 | 91 | 2 | 21840486 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP26 KRT84 SSNA1 MCM6 STIP1 EIF2AK4 PPP6R2 KLHL20 KIF11 NIN | 3.01e-04 | 1005 | 91 | 10 | 19615732 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 3.40e-04 | 498 | 91 | 7 | 36634849 | |
| Pubmed | DDX31 DST MARS1 UBR4 BAZ1B LRP6 CEP152 STIP1 NDUFA8 LARP4 PRDM16 FILIP1L | 3.48e-04 | 1429 | 91 | 12 | 35140242 | |
| Pubmed | 3.67e-04 | 11 | 91 | 2 | 18787068 | ||
| Pubmed | 3.67e-04 | 11 | 91 | 2 | 31045206 | ||
| Pubmed | 3.67e-04 | 11 | 91 | 2 | 10441735 | ||
| Pubmed | Ectodermal Organ Development Is Regulated by a microRNA-26b-Lef-1-Wnt Signaling Axis. | 3.67e-04 | 11 | 91 | 2 | 32760291 | |
| Pubmed | The malformed kidney: disruption of glomerular and tubular development. | 3.67e-04 | 11 | 91 | 2 | 10668924 | |
| Pubmed | The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway. | 3.67e-04 | 11 | 91 | 2 | 16815997 | |
| Pubmed | 3.67e-04 | 11 | 91 | 2 | 24800743 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | ROCK2 KNTC1 PPP2R5C GBF1 MARS1 ANP32B UBR4 POP1 BCCIP MCM6 STIP1 ENO2 | 4.09e-04 | 1455 | 91 | 12 | 22863883 |
| Pubmed | 4.39e-04 | 12 | 91 | 2 | 10482239 | ||
| Pubmed | Proneurogenic Ligands Defined by Modeling Developing Cortex Growth Factor Communication Networks. | 4.39e-04 | 12 | 91 | 2 | 27545711 | |
| Pubmed | SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer. | 4.39e-04 | 12 | 91 | 2 | 31911863 | |
| Pubmed | Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system. | 4.85e-04 | 138 | 91 | 4 | 28786561 | |
| Pubmed | DLG5 DDX31 MTX2 ANP32B UBR4 POP1 BAZ1B BCCIP STIP1 PPP6R2 GOLGA4 NIN | 4.96e-04 | 1487 | 91 | 12 | 33957083 | |
| Pubmed | Proteomic analysis and identification of cellular interactors of the giant ubiquitin ligase HERC2. | 4.99e-04 | 139 | 91 | 4 | 25476789 | |
| Pubmed | 5.18e-04 | 13 | 91 | 2 | 16847320 | ||
| Pubmed | Pax6 is regulated by Meis and Pbx homeoproteins during pancreatic development. | 5.18e-04 | 13 | 91 | 2 | 17049510 | |
| Pubmed | 5.18e-04 | 13 | 91 | 2 | 23622063 | ||
| Pubmed | 5.18e-04 | 13 | 91 | 2 | 26047795 | ||
| Pubmed | 5.18e-04 | 250 | 91 | 5 | 33536335 | ||
| Interaction | ANKRD20A4P interactions | 1.71e-06 | 6 | 90 | 3 | int:ANKRD20A4P | |
| Interaction | ANKRD20A2P interactions | 2.98e-06 | 7 | 90 | 3 | int:ANKRD20A2P | |
| Interaction | DCTN2 interactions | 4.26e-06 | 356 | 90 | 10 | int:DCTN2 | |
| Interaction | STK16 interactions | 6.08e-06 | 155 | 90 | 7 | int:STK16 | |
| Interaction | H3C1 interactions | ROCK2 SETD2 DDX31 ANP32B UBR4 POP1 RSF1 NSD1 BAZ1B BCCIP MCM6 DAXX PRR14L PRDM16 KIF11 | 1.01e-05 | 901 | 90 | 15 | int:H3C1 |
| Interaction | ANKRD20A1 interactions | 1.38e-05 | 11 | 90 | 3 | int:ANKRD20A1 | |
| Interaction | PPP1R13B interactions | 1.40e-05 | 176 | 90 | 7 | int:PPP1R13B | |
| Interaction | SDCBP interactions | IFNGR1 KLHL2 PDE2A TRAF5 MARS1 ANP32B SSNA1 RNF149 IFI16 PPP6R2 | 2.68e-05 | 440 | 90 | 10 | int:SDCBP |
| Interaction | ZNF692 interactions | 3.66e-05 | 42 | 90 | 4 | int:ZNF692 | |
| Interaction | APEX1 interactions | MIIP ROCK2 SLIT2 KLHL2 SETD2 ODF2L DDX31 CLTCL1 CENPF ZFR2 RSF1 NSD1 BAZ1B DAXX LARP4 KIF11 FILIP1L | 4.12e-05 | 1271 | 90 | 17 | int:APEX1 |
| Interaction | FAM229B interactions | 5.90e-05 | 3 | 90 | 2 | int:FAM229B | |
| Interaction | NPM1 interactions | ROCK2 SLIT2 SETD2 DDX31 CENPF MARS1 POP1 LTN1 NSD1 BAZ1B BCCIP CEP152 IRS1 STIP1 LARP4 KIF11 | 7.52e-05 | 1201 | 90 | 16 | int:NPM1 |
| Interaction | ANKFY1 interactions | 9.04e-05 | 236 | 90 | 7 | int:ANKFY1 | |
| Interaction | CEP57 interactions | 9.70e-05 | 165 | 90 | 6 | int:CEP57 | |
| Interaction | FGFR2 interactions | 9.79e-05 | 239 | 90 | 7 | int:FGFR2 | |
| Interaction | CIP2A interactions | 1.38e-04 | 176 | 90 | 6 | int:CIP2A | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.49e-04 | 34 | 55 | 3 | 487 | |
| GeneFamily | PHD finger proteins | 2.60e-03 | 90 | 55 | 3 | 88 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 2.82e-03 | 26 | 55 | 2 | 526 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ROCK2 SLIT2 SETD2 PPP2R5C GBF1 MTX2 DST CENPF LTN1 BAZ1B IRS1 ATP8B1 LARP4 CBLB GOLGA4 KLHL20 KIF11 FILIP1L | 7.53e-10 | 856 | 91 | 18 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ROCK2 SETD2 PPP2R5C MTX2 DST CENPF IRS1 LARP4 CBLB GOLGA4 KIF11 FILIP1L | 7.68e-08 | 466 | 91 | 12 | M13522 |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 1.72e-06 | 164 | 91 | 7 | M13108 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 5.41e-06 | 195 | 91 | 7 | M13736 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 1.57e-05 | 90 | 91 | 5 | M39250 | |
| Coexpression | GSE11386_NAIVE_VS_MEMORY_BCELL_DN | 1.91e-05 | 158 | 91 | 6 | M372 | |
| Coexpression | SASAKI_ADULT_T_CELL_LEUKEMIA | 2.69e-05 | 168 | 91 | 6 | M15171 | |
| Coexpression | AFFAR_YY1_TARGETS_DN | 3.47e-05 | 260 | 91 | 7 | M1471 | |
| Coexpression | KIM_WT1_TARGETS_DN | 3.85e-05 | 471 | 91 | 9 | M17859 | |
| Coexpression | CAMP_UP.V1_DN | 6.93e-05 | 199 | 91 | 6 | M2719 | |
| Coexpression | GSE14308_TH2_VS_TH17_UP | 7.12e-05 | 200 | 91 | 6 | M3361 | |
| Coexpression | GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN | 7.12e-05 | 200 | 91 | 6 | M4531 | |
| Coexpression | GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 7.12e-05 | 200 | 91 | 6 | M6997 | |
| Coexpression | LI_WILMS_TUMOR_ANAPLASTIC_DN | 1.18e-04 | 5 | 91 | 2 | M1216 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-07 | 184 | 91 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.36e-06 | 170 | 91 | 6 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | COPD-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 2.15e-06 | 184 | 91 | 6 | 42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-ACTC+_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.15e-06 | 184 | 91 | 6 | 39168ca2bbf1369c9fe87c67f0aaff5e3cd03151 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-06 | 185 | 91 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-06 | 190 | 91 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 194 | 91 | 6 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.92e-06 | 194 | 91 | 6 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.92e-06 | 194 | 91 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 3.48e-06 | 200 | 91 | 6 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-7|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.85e-06 | 136 | 91 | 5 | d94f0fbeb7b80d4cf0687d1924ebf8f9dd07358c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.38e-05 | 167 | 91 | 5 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-05 | 169 | 91 | 5 | 47fd4adfe54777e69a0fabf8bd34f26223f63275 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-05 | 169 | 91 | 5 | e09259d62cd3e42f0919f231ed1164db59b0b6c3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 169 | 91 | 5 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | COVID-19-Myeloid-MoAM4|Myeloid / Condition, Lineage and Cell class | 3.24e-05 | 178 | 91 | 5 | fe0017e6a1f23dc45f644b9acacc7e8aa80d0116 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 182 | 91 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 3.69e-05 | 183 | 91 | 5 | a75cda2131755931117c387f2e0ae3394efa8e80 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 3.79e-05 | 184 | 91 | 5 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | IPF-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 3.99e-05 | 186 | 91 | 5 | 962c2dada19185628ead77c32fcb07fa95114247 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-05 | 186 | 91 | 5 | a6ef5d5944af5689b5f27bef89cd05645eedbe50 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 3.99e-05 | 186 | 91 | 5 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| ToppCell | COVID-19_Mild-Neu_4|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 4.09e-05 | 187 | 91 | 5 | 714851e757c71c559ee6413a3f61d6c117c79ad2 | |
| ToppCell | IPF-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 4.20e-05 | 188 | 91 | 5 | 47bb6caf84f70a1cda7d09803afdfd5182772e66 | |
| ToppCell | IPF-Myeloid-cDC1|IPF / Disease state, Lineage and Cell class | 4.20e-05 | 188 | 91 | 5 | 2331a2bae1383820d598e93aa86c75b101069bac | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.31e-05 | 189 | 91 | 5 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 190 | 91 | 5 | 2e88e366d377d74deb53a4ea870973ce5c6532e8 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 4.41e-05 | 190 | 91 | 5 | 4225bfa10a6fb909a3ba8ac26f3541c390b46737 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-05 | 190 | 91 | 5 | 0028f886c789ba238c031eae5d96acaed4af8c25 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.41e-05 | 190 | 91 | 5 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-05 | 191 | 91 | 5 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.53e-05 | 191 | 91 | 5 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.53e-05 | 191 | 91 | 5 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.53e-05 | 191 | 91 | 5 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | COPD-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 4.53e-05 | 191 | 91 | 5 | 3480e6d27dd4291765bbbb2acdb6a2e4f02c8085 | |
| ToppCell | COPD-Myeloid-cDC1|COPD / Disease state, Lineage and Cell class | 4.64e-05 | 192 | 91 | 5 | bd3d00b094d92463b06023361a71240851a542b8 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.76e-05 | 193 | 91 | 5 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 4.76e-05 | 193 | 91 | 5 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.87e-05 | 194 | 91 | 5 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-05 | 194 | 91 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.87e-05 | 194 | 91 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-05 | 194 | 91 | 5 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.87e-05 | 194 | 91 | 5 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.99e-05 | 195 | 91 | 5 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.99e-05 | 195 | 91 | 5 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 4.99e-05 | 195 | 91 | 5 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 4.99e-05 | 195 | 91 | 5 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 5.12e-05 | 196 | 91 | 5 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | Mild|World / Disease group and Cell class | 5.12e-05 | 196 | 91 | 5 | 5e4ed4a5a437cfa002b92775992a791e27aa4c27 | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 5.12e-05 | 196 | 91 | 5 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.12e-05 | 196 | 91 | 5 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Control-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 5.12e-05 | 196 | 91 | 5 | 1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5 | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 5.12e-05 | 196 | 91 | 5 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.12e-05 | 196 | 91 | 5 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 5.24e-05 | 197 | 91 | 5 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.24e-05 | 197 | 91 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 5.24e-05 | 197 | 91 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.24e-05 | 197 | 91 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.24e-05 | 197 | 91 | 5 | c747c496ac090309b7f8a3e9d840928f12c83f2f | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 5.24e-05 | 197 | 91 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.24e-05 | 197 | 91 | 5 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.37e-05 | 198 | 91 | 5 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-stromal_related-T_reticular|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-05 | 198 | 91 | 5 | 5c96778cf5623c662c2259fe70f8665c14a161dd | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 5.37e-05 | 198 | 91 | 5 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | 5.37e-05 | 198 | 91 | 5 | da84c76afe835aeee39da04b63c03549218b5d91 | |
| ToppCell | COVID-19-lung-Fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 5.37e-05 | 198 | 91 | 5 | df3de77216f5c5d6141ec44d01c56b942f611838 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.37e-05 | 198 | 91 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.37e-05 | 198 | 91 | 5 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | 5.37e-05 | 198 | 91 | 5 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.37e-05 | 198 | 91 | 5 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.50e-05 | 199 | 91 | 5 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | BAL-Severe-cDC_1|Severe / Compartment, Disease Groups and Clusters | 5.50e-05 | 199 | 91 | 5 | 9f5750212b887f92761ade33fc6e108cd5275297 | |
| ToppCell | TCGA-Lung-Primary_Tumor|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.50e-05 | 199 | 91 | 5 | d1d035e987280607266171094db5d6362efe1ad5 | |
| ToppCell | 18-Airway-Mesenchymal-Mesenchyme_RSPO2+|Airway / Age, Tissue, Lineage and Cell class | 5.50e-05 | 199 | 91 | 5 | 7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.50e-05 | 199 | 91 | 5 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.50e-05 | 199 | 91 | 5 | f835e7ffe976843b0edbf695762d463da85793f3 | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.50e-05 | 199 | 91 | 5 | fcbb3a9c0f4c5b4c1f09db24b9f50cc1166fa43b | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 5.50e-05 | 199 | 91 | 5 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.50e-05 | 199 | 91 | 5 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 5.50e-05 | 199 | 91 | 5 | 6748d4f76703360071d5f2026d9d06bf30ccfb6d | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.50e-05 | 199 | 91 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.50e-05 | 199 | 91 | 5 | 993fa050a095017135a6e723c77cd38b9d782e58 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.50e-05 | 199 | 91 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.63e-05 | 200 | 91 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.63e-05 | 200 | 91 | 5 | 2d07237022b409c4fac6fcf99b68c8affb3007cd | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 5.63e-05 | 200 | 91 | 5 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Control_saline-Mesenchymal_myocytic|Control_saline / Treatment groups by lineage, cell group, cell type | 5.63e-05 | 200 | 91 | 5 | 5ed4261157cd51109b314818133ac3a0d34ee5fa | |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.63e-05 | 200 | 91 | 5 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 5.63e-05 | 200 | 91 | 5 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | f6be0f24e607abb9007823a54fb0b24d04990a89 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | f74b9b0e27afedd589e828d30194e8417029817a | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.63e-05 | 200 | 91 | 5 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 5.63e-05 | 200 | 91 | 5 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | af3dc76b4507bf4edd265169f5dfbbb8a19eb394 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.63e-05 | 200 | 91 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | COVID_vent|World / Disease condition, Lineage, Cell class and subclass | 5.63e-05 | 200 | 91 | 5 | 1d88e5cc4534073f27a7562e1c4b884bd67f09d9 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 5.63e-05 | 200 | 91 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.99e-06 | 50 | 60 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Disease | Leukemia, Myelocytic, Acute | 1.11e-05 | 173 | 85 | 6 | C0023467 | |
| Disease | Sotos' syndrome | 4.90e-05 | 4 | 85 | 2 | C0175695 | |
| Disease | visceral heterotaxy (implicated_via_orthology) | 1.67e-04 | 37 | 85 | 3 | DOID:0050545 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | 1.98e-04 | 869 | 85 | 10 | EFO_0004735 | |
| Disease | Chromosomal Instability | 2.27e-04 | 8 | 85 | 2 | C1257806 | |
| Disease | Acute Myeloid Leukemia, M1 | 4.77e-04 | 125 | 85 | 4 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 4.77e-04 | 125 | 85 | 4 | C1879321 | |
| Disease | stomach carcinoma (is_implicated_in) | 5.31e-04 | 12 | 85 | 2 | DOID:5517 (is_implicated_in) | |
| Disease | energy intake | 6.19e-04 | 134 | 85 | 4 | EFO_0003939 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 7.30e-04 | 14 | 85 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Neuralgia, Supraorbital | 9.59e-04 | 16 | 85 | 2 | C0038870 | |
| Disease | Neuralgia, Iliohypogastric Nerve | 9.59e-04 | 16 | 85 | 2 | C0423712 | |
| Disease | Neuralgia, Perineal | 9.59e-04 | 16 | 85 | 2 | C0423711 | |
| Disease | Neuralgia | 9.59e-04 | 16 | 85 | 2 | C0027796 | |
| Disease | thyroid volume | 9.59e-04 | 16 | 85 | 2 | EFO_0004865 | |
| Disease | Neuralgia, Atypical | 9.59e-04 | 16 | 85 | 2 | C0234247 | |
| Disease | Neuralgia, Stump | 9.59e-04 | 16 | 85 | 2 | C0234249 | |
| Disease | Paroxysmal Nerve Pain | 9.59e-04 | 16 | 85 | 2 | C0751373 | |
| Disease | Nerve Pain | 9.59e-04 | 16 | 85 | 2 | C0751372 | |
| Disease | Neuralgia, Ilioinguinal | 9.59e-04 | 16 | 85 | 2 | C0751371 | |
| Disease | Neuralgia, Vidian | 9.59e-04 | 16 | 85 | 2 | C0042656 | |
| Disease | primary ciliary dyskinesia (implicated_via_orthology) | 1.36e-03 | 19 | 85 | 2 | DOID:9562 (implicated_via_orthology) | |
| Disease | Seckel syndrome | 1.82e-03 | 22 | 85 | 2 | C0265202 | |
| Disease | spermatogenic failure (is_implicated_in) | 1.99e-03 | 23 | 85 | 2 | DOID:0111910 (is_implicated_in) | |
| Disease | stomach carcinoma (is_marker_for) | 2.17e-03 | 24 | 85 | 2 | DOID:5517 (is_marker_for) | |
| Disease | glucocorticoid receptor gene expression measurement | 2.75e-03 | 27 | 85 | 2 | EFO_0600079 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ELEENKKLECESSCI | 226 | Q9BXU7 | |
| LVNRKCQIDVCDKEN | 86 | Q5TYW2 | |
| CFQELEKAKQECQDL | 1171 | O94986 | |
| LVNRKCQIDICDKEN | 86 | Q5CZ79 | |
| DFQDFLKKCVCLDDK | 511 | Q9P2K8 | |
| LVNRKCQIDVCDKEN | 86 | Q4UJ75 | |
| DDKLILCDECNKAFH | 1196 | Q9UIG0 | |
| LDFLKCCKRNTAEEE | 261 | P28335 | |
| ADQEKLFIQKLRQCC | 36 | Q13362 | |
| KLECLKSLDLFNCEV | 111 | Q92688 | |
| AVEEKACNCLLLKVN | 331 | P09104 | |
| LENEKLFEEFLELCK | 61 | Q9UER7 | |
| KEQRQKNFVDLACEC | 846 | O43520 | |
| LKENVCQNCEKLGEL | 1541 | Q96L73 | |
| IEEVKACCKNLEALV | 441 | Q9ULW6 | |
| KLSLEEENCLIQLKC | 516 | Q9ULJ1 | |
| QCCKKINLLNDLEAR | 276 | Q86YS3 | |
| LGEKLVNLADCLCNE | 741 | O94822 | |
| LVNRKCQIDVCDKEN | 86 | Q5SQ80 | |
| DCLKACQEQIEAVLL | 241 | P30279 | |
| EVAEKCQKLFLDFLE | 21 | Q14566 | |
| SDAKCKLADLECALQ | 421 | Q9NSB2 | |
| EELAIQLDICCKKTE | 1211 | Q13439 | |
| IDKCQNNLEEIKFCL | 4971 | Q03001 | |
| ERFCALEEKCENIQK | 731 | P52732 | |
| CENEDLICFKDIKPA | 66 | Q9NQE9 | |
| QELVLRFCEKNCEKS | 146 | Q9P287 | |
| EEKCISEKQADKCLN | 926 | Q5H9U9 | |
| QLCKICAENDKDVKI | 371 | Q13191 | |
| ELKKCQCVLAADEVV | 481 | Q86VH2 | |
| EQKLKCECQALLQVA | 386 | O00408 | |
| QCKALCQELKEALQE | 501 | Q8TDM6 | |
| KSDEKNCEVLCLIDQ | 1316 | O75581 | |
| LCDIQKDNLQKKDEC | 966 | P50748 | |
| AENKCQELLCKCDQE | 121 | O15496 | |
| CLAAFILQKCKFEED | 496 | Q9H8H2 | |
| DLDLVKDFKQCPQEC | 1181 | P35568 | |
| ECENLENLCVVLLNK | 856 | Q96JM4 | |
| KQDILEEIKAACQCV | 336 | Q99575 | |
| LVNRKCQIDVCDKEN | 86 | Q5VUR7 | |
| AEIQEACCEFLKRQL | 151 | Q9Y2M5 | |
| AQEKNSKLECLLNEC | 1046 | P49454 | |
| RLDCVKASDQCLKEQ | 26 | P56159 | |
| EEECKFNKVEACVLD | 121 | P13284 | |
| EFICLLEQECERLKK | 191 | Q4L180 | |
| ELAEQLDNIAEKACC | 2016 | P12111 | |
| TEDLKECLKKQLEFC | 116 | Q71RC2 | |
| NCEEGDKLKLTCFEL | 726 | Q16666 | |
| QEAKRVALECIKQCD | 1101 | Q92538 | |
| KIDEDNLTCLEDLCK | 161 | Q92851 | |
| EIQFLCIVCAKLKQD | 151 | Q5W0V3 | |
| KECNEDCNFKELILE | 131 | P21781 | |
| LCECQFDDNLKFKNI | 126 | Q96T23 | |
| CLEEGKLVNKCALDF | 56 | P51970 | |
| CEILCNVIKNKLDCD | 746 | O43933 | |
| LELEKVNELCKDFCN | 146 | Q96KN3 | |
| FLDLKKIIDDFSECC | 1466 | Q8TE73 | |
| KILTQKEDDCDEIQC | 186 | P15260 | |
| ECKAQNQKLLDFLCR | 36 | O75170 | |
| GDVDCEKLVEQLKDC | 756 | P46019 | |
| KEELCKPNLVCEADD | 296 | Q5THK1 | |
| KKTLDQVLEDVDQCC | 176 | O75431 | |
| LCCDLLVQQVDKTKE | 6 | O95397 | |
| YNNELVKCIEELCQK | 11 | O43805 | |
| KLLEFQLALKDCEEC | 406 | P31948 | |
| DDQETRLCDNCKKEI | 6 | O14545 | |
| ELDLRGNKFECDCKA | 161 | Q8N0V4 | |
| CADCDRASEKKQDLL | 1211 | Q8N4C6 | |
| ELEKVNELCKDFCSR | 131 | P55347 | |
| RCDECDELFQSKLDL | 231 | Q9HAZ2 | |
| KLQEFRETNKEECIC | 201 | Q5JXC2 | |
| KVNFCQEKLEDTICL | 156 | Q5VXU9 | |
| AEKEGECLTLCKNEL | 191 | Q8TF17 | |
| CDKEVAFCLKRNLDT | 111 | Q9UNK4 | |
| KLKAALDCCVVDVQE | 301 | Q17R89 | |
| LELSNIKCVLEDNKC | 216 | Q15399 | |
| QEVFKDNCCKREVLN | 91 | O00463 | |
| CDLELIKVCNENSLF | 926 | P53675 | |
| AENCAVCIENFKVKD | 266 | Q8NC42 | |
| KLCECSFNDLNAKDL | 471 | Q9UPR6 | |
| EAEKRCSLLDCDLKQ | 756 | O75116 | |
| ELCEEKLDFCAQDLN | 1031 | O94813 | |
| LKYCKNPEDLECNEN | 2521 | Q9BYW2 | |
| ECLQACLDKKSENIA | 271 | Q9BZW7 | |
| DLKCDNLLLDKDFNI | 136 | Q9BXA7 | |
| IKNKICQDCDLVALL | 4386 | Q5T4S7 | |
| DLKCENLLLDKDFNI | 136 | Q96PF2 | |
| DQCDKCGKLINAVEL | 416 | P56192 | |
| VVCECNKKEDEIQNL | 211 | Q8N6V9 | |
| IQEEENIFKCNECEK | 196 | Q5CZA5 | |
| LQLQDVKKTCCEFLE | 136 | O95198 |